Naji Faezeh Sadat, Mirshekari Mehrzad, Namazi Soha, Varpaei Hesam Aldin, Esteghamati Alireza, Hemmatabadi Mahboobeh, Shirzad Nooshin
Department of Endocrinology, Vali-Asr Hospital, Endocrinology and Metabolism Research Center, Imam Khomeini Complex Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Clinical Pharmacy Department, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
J Tehran Heart Cent. 2024 Jan;19(1):14-24. doi: 10.18502/jthc.v19i1.15532.
Lipid metabolism disorders are among the most common metabolic diseases that are increasing globally and are associated with chronic metabolic disturbances. The present study aimed to determine the knowledge and practice of internal medicine physicians concerning lipid disorders according to the AHA, AACE, ESC-EAS, and NCEP-ATP-III guidelines.
This descriptive-analytical cross-sectional study selected a convenience sample of 220 internal medicine specialists from January through September 2021 in Tehran and some other Iranian cities. A 25-item researcher-designed questionnaire was used. Suggested scenarios were designed by emphasizing the points of difference in the guidelines. Content validity was approved by 10 tenured faculty members, and reliability was tested with the test-retest method.
Women comprised 60% of the population. In addition, 3.2% (n=7) of the physicians had poor knowledge, 95.0% (n=209) had moderate knowledge, and 1.8% (n=4) had good knowledge of lipid disorders based on international guidelines. Moreover, performance regarding lipid disorders was poor in 25 (11.4%), moderate in 164 (74.5%), and good in 31 (14.1%) physicians. The knowledge score decreased, whereas the practice score increased with age. The knowledge score of female physicians was significantly higher than that of their male counterparts. The knowledge score was negatively correlated with the physician's years of experience.
The knowledge and performance of internists regarding dyslipidemia were rated moderate according to the AHA, AACE, ESC-EAS and NCEP-ATP III guidelines.
脂质代谢紊乱是全球范围内日益增多的最常见代谢性疾病之一，与慢性代谢紊乱相关。本研究旨在根据美国心脏协会（AHA）、美国临床内分泌医师协会（AACE）、欧洲心脏病学会-欧洲动脉粥样硬化学会（ESC-EAS）和美国国家胆固醇教育计划成人治疗组第三次报告（NCEP-ATP-III）指南，确定内科医生对脂质紊乱的认知和实践情况。
这项描述性分析横断面研究于2021年1月至9月在德黑兰和伊朗其他一些城市选取了220名内科专家作为便利样本。使用了一份由研究人员设计的包含25个条目的问卷。通过强调指南中的差异点来设计建议场景。内容效度经10名终身教职员工认可，信度采用重测法进行测试。
女性占总人数的60%。此外，根据国际指南，3.2%（n=7）的医生对脂质紊乱知识掌握较差，95.0%（n=209）掌握中等，1.8%（n=4）掌握良好。此外，25名（11.4%）医生在脂质紊乱方面的实践较差，164名（74.5%）中等，31名（14.1%）良好。知识得分随年龄增长而降低，而实践得分随年龄增长而升高。女医生的知识得分显著高于男医生。知识得分与医生的工作年限呈负相关。
根据AHA、AACE、ESC-EAS和NCEP-ATP III指南，内科医生对血脂异常的知识和实践水平评定为中等。
